why choose us

First received: October 04, 2022

Clinical Trial: Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Study Status: Completed

Recruit Status: RECRUITING

Condition: Systemic Lupus Erythematosus (Sle)

Study Type: OBSERVATIONAL


Official Title: Efficacy of Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Brief Summary: Background:Systemic lupus erythematosus (SLE) is a disease that affects females nine times more often than males.People with SLE are often treated with cyclophosphamide (CYC).But CYC can damage a woman s ovaries; it may cause infertility.A drug called GnRHa is sometimes given to protect the ovaries during CYC therapy.But no one really knows how effective GnRHa treatment is.This natural history survey will compare women who received GnRHa during CYC therapy with those who did not.Objective:To find out whether GnRHa…

Read more